Contec Medical Systems Co.,Ltd
SZSE:300869.SZ
20.36 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 479.805 | 746.902 | 712.115 | 908.712 | 1,401.225 | 387.247 | 362.655 | 397.805 | 442.092 | 284.431 | 252.132 | 213.587 |
| Cost of Revenue
| 243.023 | 359.818 | 374.023 | 462.754 | 585.025 | 204.338 | 188.671 | 201.695 | 231 | 135.53 | 116.567 | 89.694 |
| Gross Profit
| 236.783 | 387.084 | 338.091 | 445.959 | 816.2 | 182.908 | 173.984 | 196.11 | 211.092 | 148.901 | 135.565 | 123.893 |
| Gross Profit Ratio
| 0.493 | 0.518 | 0.475 | 0.491 | 0.582 | 0.472 | 0.48 | 0.493 | 0.477 | 0.524 | 0.538 | 0.58 |
| Reseach & Development Expenses
| 105.156 | 110.6 | 93.254 | 66.06 | 48.737 | 40.567 | 34.395 | 35.007 | 38.233 | 29.867 | 29.844 | 19.28 |
| General & Administrative Expenses
| 13.576 | 16.238 | 13.476 | 9.359 | 13.453 | -10.147 | -1.694 | -8.039 | 7.591 | 5.54 | 7.261 | 7.057 |
| Selling & Marketing Expenses
| 64.188 | 117.31 | 90.213 | 66.11 | 61.162 | 52.762 | 49.619 | 52.308 | 49.331 | 41.821 | 27.464 | 25.062 |
| SG&A
| 77.764 | 151.863 | 103.689 | 75.469 | 74.615 | 42.615 | 47.925 | 44.269 | 56.922 | 47.361 | 34.725 | 32.12 |
| Other Expenses
| 121.413 | -64.8 | 0.119 | 2.248 | 0.835 | -12.935 | -11.709 | 1.246 | 23.191 | 12.756 | 10.926 | 10.571 |
| Operating Expenses
| 304.333 | 200.35 | 215.541 | 154.835 | 113.88 | 112.178 | 110.04 | 101.172 | 116.344 | 96.518 | 83.752 | 67.893 |
| Operating Income
| -67.55 | 186.734 | 219.276 | 405.745 | 714.636 | 81.594 | 69.472 | 84.592 | 96.757 | 58.643 | 49.454 | 50.349 |
| Operating Income Ratio
| -0.141 | 0.25 | 0.308 | 0.447 | 0.51 | 0.211 | 0.192 | 0.213 | 0.219 | 0.206 | 0.196 | 0.236 |
| Total Other Income Expenses Net
| -6.337 | -0.608 | 0.119 | 2.248 | 0.835 | 0.311 | -0.119 | 3.463 | 23.079 | 12.473 | 10.836 | 10.519 |
| Income Before Tax
| -73.887 | 186.126 | 219.394 | 407.993 | 715.471 | 81.905 | 69.352 | 88.055 | 119.836 | 71.116 | 60.289 | 60.868 |
| Income Before Tax Ratio
| -0.154 | 0.249 | 0.308 | 0.449 | 0.511 | 0.212 | 0.191 | 0.221 | 0.271 | 0.25 | 0.239 | 0.285 |
| Income Tax Expense
| 4.015 | 20.36 | 23.192 | 55.64 | 102.076 | 8.124 | 7.321 | 10.998 | 16.343 | 9.582 | 5.828 | 7.077 |
| Net Income
| -77.903 | 165.766 | 196.203 | 352.353 | 613.395 | 73.781 | 62.031 | 77.057 | 103.493 | 61.534 | 54.461 | 53.79 |
| Net Income Ratio
| -0.162 | 0.222 | 0.276 | 0.388 | 0.438 | 0.191 | 0.171 | 0.194 | 0.234 | 0.216 | 0.216 | 0.252 |
| EPS
| -0.19 | 0.41 | 0.49 | 0.88 | 1.53 | 0.18 | 0.17 | 0.21 | 0.3 | 0.18 | 0.54 | 0.56 |
| EPS Diluted
| -0.19 | 0.4 | 0.48 | 0.88 | 1.53 | 0.18 | 0.17 | 0.21 | 0.3 | 0.18 | 0.54 | 0.56 |
| EBITDA
| -10.641 | 261.027 | 260.667 | 428.72 | 735.402 | 97.284 | 85.555 | 102.676 | 106.456 | 65.826 | 63.8 | 72.007 |
| EBITDA Ratio
| -0.022 | 0.349 | 0.366 | 0.472 | 0.525 | 0.251 | 0.236 | 0.258 | 0.241 | 0.231 | 0.253 | 0.337 |